Wilhelm Krek
Biomedical Sciences
ProteoMedix
Switzerland
Biography
Prof. Dr. Wilhelm Krek co-founded ProteoMediX AG and is a world-leader in cancer cell signaling and a full professor of cell biology at ETH Zurich since 2003. Earlier he worked at the Friedrich Miescher Institute for Biomedical Research (FMI), Basel and at the Dana Farber Cancer Institute/Harvard Medical School in Boston. Wilhelm Krek is also co-founder and Chairman of the Competence Center for Systems Physiology and Metabolic Diseases (CC-SPMD), a joint center of ETH and University-Hospital Zurich in medical systems biology.
Research Interest
Biomedical Research
